The capacity of polymeric nanoparticles (NPs) to reach the target regardless to the administration route is a neglected field of investigation in the pharmaceutical nanotechnology. Therefore, after having demonstrated in previous studies that glycopeptide-engineered NPs (g7-NPs) were able to reach the brain after intravenous administrations in rodents, this paper aimed to evaluate if they can reach the Central Nervous System (CNS) also when administered by different routes. The confocal microphotographs on murine brain sections showed the capability of g7-NPs to reach the target also after intraperitoneal, intranasal and oral administrations. These highlights could open new vistas to a future application of the g7-NPs in the therapeutic treatments of CNS diseases.

Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents / Tosi, Giovanni; Ruozi, Barbara; Belletti, Daniela; Vilella, Antonietta; Zoli, Michele; Vandelli, Maria Angela; Forni, Flavio. - In: NANOMEDICINE. - ISSN 1748-6963. - STAMPA. - 8:9(2013), pp. 1373-1383. [10.2217/nnm.12.172]

Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents.

TOSI, Giovanni;RUOZI, Barbara;BELLETTI, Daniela;VILELLA, ANTONIETTA;ZOLI, Michele;VANDELLI, Maria Angela;FORNI, Flavio
2013

Abstract

The capacity of polymeric nanoparticles (NPs) to reach the target regardless to the administration route is a neglected field of investigation in the pharmaceutical nanotechnology. Therefore, after having demonstrated in previous studies that glycopeptide-engineered NPs (g7-NPs) were able to reach the brain after intravenous administrations in rodents, this paper aimed to evaluate if they can reach the Central Nervous System (CNS) also when administered by different routes. The confocal microphotographs on murine brain sections showed the capability of g7-NPs to reach the target also after intraperitoneal, intranasal and oral administrations. These highlights could open new vistas to a future application of the g7-NPs in the therapeutic treatments of CNS diseases.
8
9
1373
1383
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents / Tosi, Giovanni; Ruozi, Barbara; Belletti, Daniela; Vilella, Antonietta; Zoli, Michele; Vandelli, Maria Angela; Forni, Flavio. - In: NANOMEDICINE. - ISSN 1748-6963. - STAMPA. - 8:9(2013), pp. 1373-1383. [10.2217/nnm.12.172]
Tosi, Giovanni; Ruozi, Barbara; Belletti, Daniela; Vilella, Antonietta; Zoli, Michele; Vandelli, Maria Angela; Forni, Flavio
File in questo prodotto:
File Dimensione Formato  
Tosi et al, Nanomedicine 2013 , 8(9), 1373-1383.pdf

non disponibili

Tipologia: Post-print dell'autore (bozza post referaggio)
Dimensione 5.9 MB
Formato Adobe PDF
5.9 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/814489
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 24
social impact